22(R)-hydroxycholesterol and pioglitazone synergistically decrease cholesterol ester via the PPARγ-LXRα-ABCA1 pathway in cholesterosis of the gallbladder.
Cholesterosis is a disease of cholesterol metabolism characterized by the presence of excessive lipid droplets in the cytoplasm. These lipid droplets are mainly composed of cholesterol esters derived from free cholesterol. The removal of excess cholesterol from gallbladder epithelial cells (GBECs) is very important for the maintenance of intracellular cholesterol homeostasis and the preservation of gallbladder function. Several lines of evidence have indicated that the activation of either peroxisome proliferator-activated receptor gamma (PPARγ) or liver X receptor α (LXRα) relates to cholesterol efflux. While pioglitazone can regulate the activation of PPARγ, 22(R)-hydroxycholesterol can activate LXRα and is a metabolic intermediate in the biosynthesis of steroid hormones. However, the effect of 22(R)-hydroxycholesterol in combination with pioglitazone on cholesterosis of the gallbladder is unclear. GBECs were treated with pioglitazone, 22(R)-hydroxycholesterol or PPARγ siRNA followed by Western blot analysis for ATP-binding cassette transporter A1 (ABCA1), PPARγ and LXRα. Cholesterol efflux to apoA-I was determined, and Oil Red O staining was performed to monitor variations in lipid levels in treated GBECs. Our data showed that 22(R)-hydroxycholesterol can modestly up-regulate LXRα while simultaneously increasing ABCA1 by 56%. The combination of 22(R)-hydroxycholesterol and pioglitazone resulted in a 3.64-fold increase in ABCA1 expression and a high rate of cholesterol efflux. Oil Red O staining showed an obvious reduction in the lipid droplets associated with cholesterosis in GBECs. In conclusion, the present findings indicate that the anti-lipid deposition action of 22(R)-hydroxycholesterol combined with pioglitazone involves the activation of the PPARγ-LXRα-ABCA1 pathway, increased ABCA1 expression and the efflux of cholesterol from GBECs. Thus, 22(R)-hydroxycholesterol synergistically combined with pioglitazone to produce a remarkable effect on lipid deposition in cholesterosis GBECs.
Department of General Surgery, Institute for Minimally Invasive Surgery, Zhongda Hospital Southeast University, Medical School of Southeast University, Nanjing, Jiangsu 210009, China. Electronic address: wjm730222@163.com.
Jing-Min
JM
Wang
Department of General Surgery, Institute for Minimally Invasive Surgery, Zhongda Hospital Southeast University, Medical School of Southeast University, Nanjing, Jiangsu 210009, China. Electronic address: 8888dd@163.com.
Dong
D
Wang
Department of General Surgery, Institute for Minimally Invasive Surgery, Zhongda Hospital Southeast University, Medical School of Southeast University, Nanjing, Jiangsu 210009, China. Electronic address: tyytyz@sina.com.
Yu-Yan
YY
Tan
Department of General Surgery, Institute for Minimally Invasive Surgery, Zhongda Hospital Southeast University, Medical School of Southeast University, Nanjing, Jiangsu 210009, China. Electronic address: zhao_gang7@126.com.
Gang
G
Zhao
Department of General Surgery, Institute for Minimally Invasive Surgery, Zhongda Hospital Southeast University, Medical School of Southeast University, Nanjing, Jiangsu 210009, China. Electronic address: zlji@me.com.
Zhen-Ling
ZL
Ji
D064286:ATP Binding Cassette Transporter 1 / Q000502:physiology*; D002478:Cells, Cultured; D002788:Cholesterol Esters / Q000378:metabolism*; D004357:Drug Synergism; D004847:Epithelial Cells / Q000378:metabolism; D005704:Gallbladder / Q000166:cytology; D005705:Gallbladder Diseases / Q000188:drug therapy*; D006801:Humans; D006888:Hydroxycholesterols / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000071518:Liver X Receptors; D057093:Orphan Nuclear Receptors / Q000502:physiology*; D047495:PPAR gamma / Q000502:physiology*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
C577836:ABCA1 protein, human; D064286:ATP Binding Cassette Transporter 1; D002788:Cholesterol Esters; D006888:Hydroxycholesterols; D000071518:Liver X Receptors; C000605213:NR1H3 protein, human; D057093:Orphan Nuclear Receptors; D047495:PPAR gamma; D045162:Thiazolidinediones; C003585:22-hydroxycholesterol; D000077205:Pioglitazone
22(R)-hydroxycholesterol; ABCA1; Cholesterosis; LXRα; PPARγ; Pioglitazone